UNSPSC 51182008: Fluoxymesterone

This classification denotes a therapeutic androgen and anabolic steroid with the molecular formula C20H29FO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9JU12S4YFY, chemically known as 11-beta,17-beta-dihydroxy-9-alpha-fluoro-17-alpha-methyl-4-androster-3-one but generally known as fluoxymesterone, which bears US NIH Compound Identifier 6446. European Medicines Agency schedules Fluoxymesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07724MIG.

UNSPSC 51182008 Fluoxymesterone, a Commodity code, describes procurement of this anabolic steroid pharmaceutical, which state and local governments acquire primarily for correctional-facility medical services, public-health clinics, and institutional healthcare programs. The code encompasses the active pharmaceutical ingredient and finished dosage forms (typically tablets) used in treatment regimens for hormone replacement and specific medical conditions within public-sector healthcare delivery. State and local buyers under this code include state departments of corrections, county jails, municipal health departments, and state Medicaid programs that serve indigent and institutionalized populations.

The source provided contains no recent state and local contract opportunities tagged to UNSPSC 51182008, making current market activity under this code not measurable from available records. Without posted RFP, RFQ, IFB, or ITB notices, geographic concentration and representative recent procurement patterns cannot be characterized. Procurement analysts evaluating entry into this commodity should monitor state corrections procurement channels, county detention-services RFQs, and state pharmaceutical-supply cooperative-purchasing vehicles for emerging solicitations.